©istock.com/Andrea Obzerova
Interdisciplinary CompetenceMolecular Diagnostics
Know how in the analysis of genetic material.
For the benefit of patients.

IllnessInflammatory bowel diseases + infantile enterocolitis, monogenic; DD

Summary

Short information

Comprehensive differential diagnostic panel for inflammatory intestinal diseases and infantile enterocolitis, monogenic, comprising 65 curated genes according to the clinical signs

ID
EP3392
Number of genes
62 Accredited laboratory test
Examined sequence length
34,2 kb (Core-/Core-canditate-Genes)
133,9 kb (Extended panel: incl. additional genes)
Analysis Duration
on request
Test material
  • EDTA-anticoagulated blood (3-5 ml)
Diagnostic indications

NGS +

 

Gene panel

Selected genes

NameExon Length (bp)OMIM-GReferenz-Seq.Heredity
ADAM172475NM_003183.6AR
EPCAM945NM_002354.3AR
FOXP31296NM_014009.4XL
GUCY2C3222NM_004963.4AD
IL10RA1737NM_001558.4AR
IL10RB978NM_000628.5AR
MEFV2346NM_000243.3AD, AR
NLRC43075NM_021209.4AD
SAMD94770NM_001193307.2AD
SKIC23741NM_006929.5AR
SKIC34695NM_014639.4AR
STAT12253NM_007315.4AD, AR
TTC7A2577NM_020458.4AR
ADA1092NM_000022.4AR
AICDA597NM_020661.4AR
ANO13232NM_018043.6AR
BTK1980NM_000061.3XL
CD3G549NM_000073.3AR
CD40LG786NM_000074.3XLR
COL7A18835NM_000094.4AR
CTLA4525NM_001037631.3AD
CYBA588NM_000101.4AR
CYBB1713NM_000397.4XL
CYBC1673AR
DCLRE1C2079NM_001033855.3AR
DKC11545NM_001363.5XLR
DOCK86300NM_203447.4AR
FERMT12034NM_017671.5AR
G6PC31041NM_138387.4AR
HPS12103NM_000195.5AR
HPS42127NM_022081.6AR
HPS62328NM_024747.6AR
ICOS600NM_012092.4AR
IL10537NM_000572.3AR
IL21462NM_001207006.3AR
IL2RA819NM_000417.3AR
IL2RG1110NM_000206.3XL
ITGB22310NM_000211.5AR
LIG42736NM_002312.3AR
LRBA8556NM_001199282.2AR
MVK1191NM_000431.4AR
NCF11173NM_000265.6AR
NCF21581NM_000433.4AR
NCF41020NM_000631.5AR
NPC13837NM_000271.5AR
OTULIN1066NM_138348.6AR
PIK3CD3135NM_005026.5AR
PIK3R12175NM_181523.3AD, AR
PLCG23798NM_002661.5AD
PTEN1212NM_000314.8AD
RAG13132NM_000448.3AR
RAG21584NM_000536.4AR
RTEL13732NM_032957.5AR
SH2D1A378NM_001114937.3XL
SLC37A41291NM_001164277.2AR
STAT32313NM_139276.3AD
STXBP21773NM_006949.4AR
TGFBR11512NM_004612.4AD
TGFBR21704NM_003242.6AD
WAS1509NM_000377.3XL
XIAP1494NM_001167.4XL
ZAP701860NM_001079.4AR

Informations about the disease

Clinical Comment

Infantile enterocolitis and monogenic inflammatory bowel disease include chronic inflammatory bowel disease and inflammatory bowel disease like intestinal inflammation. The onset of disease of intestinal inflammation is less than 2 years. Histology confirms intestinal inflammation at the first endoscopy at less than 2.5 years of age. This is a fairly large and extremely heterogeneous group based on the abovementioned criteria. All Mendelian inheritance patterns are observed. Since the molecular genetic yield for this group of disorders is essentially unknown, a negative DNA test result by no means excludes the clinical diagnosis.

Reference: -

 

Synonyms
  • Allelic: Diabetes mellitus, insulin-dependent, 12 (CTLA4)
  • Allelic: Diabetes, mellitus, insulin-dependent, susceptibility to, 10 (IL2RA)
  • Allelic: Dursun syndrome (G6PC3)
  • Allelic: Dysmorphic features [panelapp] (ANO1)
  • Allelic: Epidermolysis bullosa, pretibial (COL7A1)
  • Allelic: Esophageal cancer, somatic (TGFBR2)
  • Allelic: Familial cold autoinflammatory syndrome 3 (PLCG2)
  • Allelic: Familial cold autoinflammatory syndrome 4 (NLRC4)
  • Allelic: Glioma susceptibility 2 (PTEN)
  • Allelic: Graft-versus-host disease, protection against (IL10)
  • Allelic: HIV-1, susceptibility to (IL10)
  • Allelic: Hashimoto thyroiditis (CTLA4)
  • Allelic: Hepatitis B virus, susceptibility to (IL10RB)
  • Allelic: Incontinentia pigmenti (IKBKG)
  • Allelic: Macrocephaly/autism syndrome (PTEN)
  • Allelic: Meconium ileus (GUCY2C)
  • Allelic: Meningioma (PTEN)
  • Allelic: Mevalonic aciduria (MVK)
  • Allelic: Monosomy 7 myelodysplasia + leukemia syndrome 2 (SAMD9)
  • Allelic: Multiple myeloma, resistance to (LIG4)
  • Allelic: Multiple self-healing squamous epithelioma, susceptibility to (TGFBR1)
  • Allelic: Neutrophilic dermatosis, acute febrile (MEFV)
  • Allelic: Omenn syndrome (DCLRE1C, RAG1, RAG2)
  • Allelic: Porokeratosis 3, multiple types (MVK)
  • Allelic: Prostate cancer, somatic (PTEN)
  • Allelic: Pulmonary fibrosis and/or bone marrow failure, telomere-related, 3 (RTEL1)
  • Allelic: Rheumatoid arthritis, progression of (IL10)
  • Allelic: SHORT syndrome (PIK3R1)
  • Allelic: Systemic lupus erythematosus, susceptibility to (CTLA4)
  • Allelic: Thrombocytopenia, XL (WAS)
  • Allelic: Thrombocytopenia, XL, intermittent (WAS)
  • Allelic: Toenail dystrophy, isolated (COL7A1)
  • Allelic: Transient bullous of the newborn (COL7A1))
  • Allelic: Tumoral calcinosis, familial, normophosphatemic (SAMD9)
  • Adenosine deaminase deficiency, partial (ADA)
  • Agammaglobulinemia 7, AR (PIK3R1)
  • Agammaglobulinemia, XL 1 (BTK)
  • Allelic: Polymicrogyria, perisylvian, with cerebellar hypoplasia + arthrogryposis (PI4KA)
  • Allelic: Spastic paraplegia 84, AR (PI4KA)
  • Alpha/beta T-cell lymphopenia, g/d T-cell exp., severe cytomegalov. infection, autoimmunity (RAG1)
  • Autoimmune disease, multisystem, infantile-onset, 1 (STAT3)
  • Autoimmune disease, multisystem, infantile-onset, 2 (ZAP70)
  • Autoimmune lymphoproliferative syndrome, type V (CTLA4)
  • Autoinflammation with infantile enterocolitis (NLRC4)
  • Autoinflammation, antibody deficiency, immune dysregulation syndrome (PPLCG2)
  • Autoinflammation, panniculitis + dermatosis syndrome (OTULIN)
  • Celiac disease, susceptibility to, 3 (CTLA4)
  • Chronic granulomatous disease 1, AR (NFC1)
  • Chronic granulomatous disease 2, AR (NFC2)
  • Chronic granulomatous disease 4, AR (CYBA)
  • Chronic granulomatous disease 5, AR (CYBC1 syn. C17orf62)
  • Chronic granulomatous disease, XL (CYBB)
  • Colorectal cancer, hereditary nonpolyposis, type 6 (TGFBR2)
  • Colorectal cancer, hereditary nonpolyposis, type 8 (EPCAM)
  • Combined cellular + humoral immune defects with granulomas (RAG1, RAG2)
  • Combined immunodeficiency, XL, moderate (IL2RG)
  • Cowden syndrome 1 (PTEN)
  • Diarrhea 5, with tufting enteropathy, congenital (EPCAM)
  • Diarrhea 6 (GUCY2C)
  • Dyskeratosis congenita, AD 4 (RTEL1)
  • Dyskeratosis congenita, AR 5 (RTEL1)
  • Dyskeratosis congenita, XL (DKC1)
  • Ectodermal dysplasia + immunodeficiency 1 (IKBKG)
  • Epidermolysis bullosa dystrophica inversa (COL7A1)
  • Epidermolysis bullosa dystrophica, AD + AR (COL7A1)
  • Epidermolysis bullosa dystrophica, Bart type (COL7A1)
  • Epidermolysis bullosa dystrophica, localisata variant (COL7A1)
  • Epidermolysis bullosa pruriginosa (COL7A1)
  • Familial Mediterranean fever, AD + AR (MEFV)
  • Gastrointestinal defects + immunodeficiency syndrome (TTC7A)
  • Gastrointestinal defects + immunodeficiency syndrome 2 (PI4KA)
  • Glycogen storage disease Ib + Ic (SLC37A4)
  • Haemorrhagic diarrhoea [panelapp] (ANO1)
  • Hemophagocytic lymphohistiocytosis, familial, 5 (STXBP2)
  • Hermansky-Pudlak syndrome 1 (HPS1)
  • Hermansky-Pudlak syndrome 4 (HPS4)
  • Hermansky-Pudlak syndrome 6 (HPS6)
  • Hyper-IgD syndrome (MVK)
  • Hyper-IgE recurrent infection syndrom (STAT3)
  • Hyper-IgE recurrent infection syndrome, AR (DOCK8)
  • Immunodeficiency 14 (PIK3CD)
  • Immunodeficiency 17, CD3 gamma deficient (CD3G)
  • Immunodeficiency 31A, mycobacteriosis, AD (STAT1)
  • Immunodeficiency 31B, mycobacterial + viral infections, AR (STAT1)
  • Immunodeficiency 31C, chronic mucocutaneous candidiasis, AD (STAT1)
  • Immunodeficiency 33 (IKBKG)
  • Immunodeficiency 34, mycobacteriosis, XL (CYBB)
  • Immunodeficiency 36 (PIK3R1)
  • Immunodeficiency 41 with lymphoproliferation + autoimmunity (IL2RA)
  • Immunodeficiency 48 (ZAP70)
  • Immunodeficiency with hyper-IgM, type 2 (AICCDA)
  • Immunodeficiency, XL, with hyper-IgM (CD40LG)
  • Immunodeficiency, common variable, 1 (ICOS)
  • Immunodeficiency, common variable, 11 (IL21)
  • Immunodeficiency, common variable, 8, with autoimmunity (LSBA)
  • Immunodysregulation, polyendocrinopathy + enteropathy, XL (FOXP3)
  • Impaired intestinal peristalsis [panelapp] (ANO1)
  • Inflammatory bowel disease 25, early onset, AR (IL10RB)
  • Inflammatory bowel disease 28, early onset, AR (IL10RA)
  • Inflammatory skin + bowel disease, neonatal, 1 (ADAM17)
  • Isolated growth hormone deficiency, type III, with agammaglobulinemia (BTK)
  • Kindler syndrome (FERMT1)
  • LIG4 syndrome (LIG4)
  • Leukocyte adhesion deficiency (ITGB2)
  • Lhermitte-Duclos syndrome (PTEN)
  • Loeys-Dietz syndrome 1 (TGFBR1)
  • Loeys-Dietz syndrome 2 (TGFBR2)
  • Lymphoproliferative syndrome, XL, 1 (Sh2D1A)
  • Lymphoproliferative syndrome, XL, 2 (XIAP)
  • MIRAGE syndrome (SAMD9)
  • Neutropenia, severe congenital 4, AR (G6PC3)
  • Neutropenia, severe congenital, XL (WAS)
  • Niemann-Pick disease, type C1 + D (NPC1)
  • Severe combined immunodeficiency due to ADA deficiency (ADA)
  • Severe combined immunodeficiency, Athabascan type (DCLRE1C)
  • Severe combined immunodeficiency, B cell-negative (RAG1, RAG2)
  • Severe combined immunodeficiency, XL (IL2RG)
  • Trichohepatoenteric syndrome 1 (TTC37)
  • Trichohepatoenteric syndrome 2 (SKIV2L)
  • Wiskott-Aldrich syndrome (WAS)
Heredity, heredity patterns etc.
  • AD
  • AR
  • XL
  • XLR
OMIM-Ps
  • Multiple OMIM-Ps
ICD10 Code

Bioinformatics and clinical interpretation

No text defined